X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
index medicus (131) 131
male (90) 90
female (86) 86
middle aged (61) 61
adult (60) 60
pharmacology & pharmacy (53) 53
pharmacokinetics (49) 49
infectious diseases (43) 43
animals (40) 40
hiv infections - drug therapy (40) 40
drug interactions (36) 36
analysis (34) 34
hiv (32) 32
aged (31) 31
research (31) 31
efficacy (30) 30
safety (30) 30
drug therapy, combination (28) 28
anti-hiv agents - pharmacokinetics (27) 27
pyridazines - pharmacokinetics (27) 27
immunology (26) 26
double-blind (24) 24
placebo-controlled trial (23) 23
treatment outcome (23) 23
virology (23) 23
anti-hiv agents - administration & dosage (22) 22
article (22) 22
adolescent (21) 21
etravirine (21) 21
reverse transcriptase inhibitors - pharmacokinetics (21) 21
microbiology (20) 20
neurosciences (20) 20
pyridazines - administration & dosage (20) 20
anti-hiv agents - adverse effects (19) 19
risk factors (19) 19
tmc125 etravirine (19) 19
antiretroviral therapy (18) 18
experienced hiv-1-infected patients (18) 18
metabolism (18) 18
antiviral agents (17) 17
care and treatment (17) 17
cross-over studies (17) 17
health aspects (17) 17
hiv protease inhibitors - pharmacokinetics (17) 17
medicine (17) 17
mice (17) 17
proteins (17) 17
pyridazines - adverse effects (17) 17
research article (17) 17
reverse transcriptase inhibitors - administration & dosage (17) 17
young adult (17) 17
hiv-1 - drug effects (16) 16
stroke (16) 16
aged, 80 and over (15) 15
cardiac & cardiovascular systems (15) 15
darunavir (15) 15
management (15) 15
reverse transcriptase inhibitors - adverse effects (15) 15
therapy (15) 15
anti-hiv agents - therapeutic use (14) 14
atrial fibrillation (14) 14
dose-response relationship, drug (14) 14
drug therapy (14) 14
medicine & public health (14) 14
pharmacology (14) 14
physiology (14) 14
ritonavir (14) 14
cell biology (13) 13
human immunodeficiency virus--hiv (13) 13
infection (13) 13
multidisciplinary sciences (13) 13
science (13) 13
time factors (13) 13
usage (13) 13
biochemistry (12) 12
biochemistry & molecular biology (12) 12
chemistry (12) 12
enzymes (12) 12
hiv infections - virology (12) 12
hiv-1 (12) 12
in-vivo (12) 12
internal medicine (12) 12
neurology (12) 12
patients (12) 12
protease inhibitors (12) 12
resistance (12) 12
expression (11) 11
hiv protease inhibitors - administration & dosage (11) 11
mutation (11) 11
physiological aspects (11) 11
prognosis (11) 11
studies (11) 11
surgery (11) 11
antiretroviral drugs (10) 10
food science & technology (10) 10
gene expression (10) 10
hiv protease inhibitors - blood (10) 10
mortality (10) 10
pharmacology/toxicology (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Robarts - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Credit Valley Hospital - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 10/2014, Volume 69, Issue 10, p. 2591
  The ability to dose antiretroviral agents once daily simplifies the often complex therapeutic regimens required for the successful treatment of HIV... 
Protease inhibitors | Human immunodeficiency virus--HIV | Pharmacology | Drug dosages | Clinical outcomes
Journal Article
Current HIV research, ISSN 1570-162X, 2010, Volume 8, Issue 7, pp. 564 - 576
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 5/2017, Volume 56, Issue 5, pp. 525 - 536
Etravirine is a non-nucleoside reverse transcriptase inhibitor indicated in combination with other antiretrovirals for treatment-experienced HIV patients... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | TRANSCRIPTASE INHIBITOR ETRAVIRINE | THERAPY | GENOTYPE | WARFARIN | QUANTIFICATION | TMC125 | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | MODEL | INDIVIDUALIZATION | DESIGNS | HIV Infections - blood | HIV-1 - metabolism | Anti-Retroviral Agents - pharmacokinetics | HIV-1 - drug effects | HIV Infections - genetics | Humans | Cytochrome P-450 CYP2C19 - genetics | Male | Reverse Transcriptase Inhibitors - administration & dosage | Cytochrome P-450 CYP2C9 - genetics | Reverse Transcriptase Inhibitors - pharmacokinetics | Anti-Retroviral Agents - administration & dosage | Drug Interactions - physiology | Pyridazines - administration & dosage | Adult | Cytochrome P-450 CYP2C19 - metabolism | Female | HIV Infections - drug therapy | Polymorphism, Genetic - genetics | Pyridazines - pharmacokinetics | Clinical Trials as Topic - methods | Drug Therapy, Combination | Cytochrome P-450 CYP2C9 - metabolism | Usage | Care and treatment | Etravirine | HIV patients | Management | HIV (Viruses) | Pharmacokinetics | Health aspects | Cytochrome | Studies | Antiretroviral drugs | Genotype & phenotype | Acquired immune deficiency syndrome--AIDS | Metabolites | Human immunodeficiency virus--HIV | Population | Systematic review | Adults | Metabolism | Drug dosages
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Hepatology, ISSN 0270-9139, 12/2018, Volume 68, Issue 6, pp. 2145 - 2157
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 08/2014, Volume 54, Issue 8, pp. 949 - 957
This study compared the bioavailability of two candidate fixed‐dose combinations (FDCs: G003 and G004) of darunavir/cobicistat 800/150 mg with that of... 
fixed‐dose combination | darunavir | cobicistat | bioavailability | pharmacoenhancer | fixed-dose combination | EFFICACY | SAFETY | HIV-1-INFECTED PATIENTS | ANTIRETROVIRAL THERAPY | PROTEASE INHIBITORS | TREATMENT-NAIVE | HIV | TREATMENT-EXPERIENCED PATIENTS | PHARMACOLOGY & PHARMACY | LOPINAVIR/RITONAVIR | ONCE-DAILY DARUNAVIR/RITONAVIR | Thiazoles - blood | Darunavir | Humans | Middle Aged | Biological Availability | Cytochrome P-450 CYP3A Inhibitors - pharmacokinetics | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Healthy Volunteers | Carbamates - pharmacokinetics | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Young Adult | Sulfonamides - blood | Ritonavir - adverse effects | HIV Protease Inhibitors - pharmacokinetics | Adult | Female | HIV Protease Inhibitors - adverse effects | HIV Protease Inhibitors - blood | Cytochrome P-450 CYP3A Inhibitors - administration & dosage | Cytochrome P-450 CYP3A Inhibitors - blood | Ritonavir - administration & dosage | Ritonavir - blood | Carbamates - blood | HIV Protease Inhibitors - administration & dosage | Sulfonamides - pharmacokinetics | Cross-Over Studies | Ritonavir - pharmacokinetics | Sulfonamides - adverse effects | Carbamates - adverse effects | Cytochrome P-450 CYP3A Inhibitors - adverse effects | Cobicistat | Drug Combinations | Sulfonamides - administration & dosage | Usage | Dosage and administration | Drug therapy, Combination | Pharmacokinetics | Analysis | Short term
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2018, Volume 13, Issue 10, p. e0204974
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2008, Volume 52, Issue 12, pp. 4228 - 4232
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2018, Volume 23, Issue 7, pp. 555 - 566
Background: This double-blind, first-in-human Phase I study evaluated pharmacokinetics, safety and tolerability of AL-794 (prodrug of ALS-033719), a potent... 
INFECTIOUS DISEASES | PHARMACOLOGY & PHARMACY | MANAGEMENT | VIROLOGY
Journal Article
Journal Article